RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFR

Oncotarget

Volumn 8, Issue 42, 2017, Pages 72633-72651

  Li, Haiping ^a   Al Japairai, K ^a   Tao, Yong ^a   Xiang, Zheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; EGFR; Glycosylation; Proliferation; RPN2

Indexed keywords

EID: 85054481693     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.20005     Document Type: Article

References (47)

1. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490-502.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:10-29.
3. Crimaudo C, Hortsch M, Gausepohl H, Meyer DI. Human ribophorins i and ii: the primary structure and membrane topology of two highly conserved rough endoplasmic reticulum-specific glycoproteins. EMBO J. 1987;6:75-82.
4. Hortsch M, Avossa D, Meyer DI. Characterization of secretory protein translocation: ribosome-membrane interaction in endoplasmic reticulum. J Cell Biol. 1986;103:241-53.
5. Kelleher DJ, Kreibich G, Gilmore R. Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins i and ii and a 48 kd protein. Cell. 1992;69:55-65.
6. Kelleher DJ, Gilmore R. An evolving view of the eukaryotic oligosaccharyltransferase. Glycobiology. 2006;16:47R-62R.
7. Fujiwara T, Takahashi R, Kosaka N, Nezu Y, Kawai A, Ozaki T, Ochiya T. Rpn2 gene confers osteosarcoma cell malignant phenotypes and determines clinical prognosis. Mol Ther Nucleic Acids. 2014;3:e189.
8. Yu F, Yagishita S, Takeshita F, Yamamoto Y, Kuwano K, Ochiya T. Prognostic and therapeutic impact of rpn2-mediated tumor malignancy in non-small-cell lung cancer. Oncotarget. 2015;6:3335-45. https://doi.org/10.18632/oncotarget.2793.
9. Fujita Y, Takeshita F, Mizutani T, Ohgi T, Kuwano K, Ochiya T. A novel platform to enable inhaled naked rnai medicine for lung cancer. Sci Rep. 2013;3:3325.
10. Tominaga N, Hagiwara K, Kosaka N, Honma K, Nakagama H, Ochiya T. Rpn2-mediated glycosylation of tetraspanin cd63 regulates breast cancer cell malignancy. Mol Cancer. 2014;13:134.
11. Ageberg M, Lindmark A. Characterisation of the biosynthesis and processing of the neutrophil granule membrane protein cd63 in myeloid cells. Clin Lab Haematol. 2003;25:297-306.
12. Honma K, Iwaokoizumi K, Takeshita F, Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K, Ochiya T. Rpn2 gene confers docetaxel resistance in breast cancer. Nat Med. 2008;14:939-48.
13. Zhang J, Yan B, Späth SS, Hu Q, Cornelius S, Guan D, Shao J, Hagiwara K, Waes CV, Chen Z. Integrated transcriptional profiling and genomic analyses reveal rpn2 and hmgb1 as promising biomarkers in colorectal cancer. Cell Biosci. 2015;5:53.
14. Carpenter G, Stoscheck CM, Soderquist AM. Epidermal growth factor. J Biol Chem. 1979;48:193.
15. Yarden Y. The egfr family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001;4:S3-8.
16. Ellina MI, Bouris P, Aletras AJ, Theocharis AD, Kletsas D, Karamanos NK. Egfr and her2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules. Biochim Biophys Acta. 2014;1840:2651-61.
17. Fernandes H, Cohen S, Bishayee S. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRviii/deltaEGFR) expressed in cancer cells. J Biol Chem. 2001;276:5375-83.
18. Coskun Ü, Grzybek M, Drechsel D, Simons K. Regulation of human egf receptor by lipids. Proc Natl Acad Sci U S A. 2011;108:9044-8.
19. Lax I, Bellot F, Howk R, Ullrich A, Givol D, Schlessinger J. Functional analysis of the ligand binding site of egf-receptor utilizing chimeric chicken/human receptor molecules. E J. 1989;8:421-7.
20. Taylor ES, Pol-Fachin L, Lins RD, Lower SK. Conformational stability of the epidermal growth factor (egf) receptor as influenced by glycosylation, dimerization and egf hormone binding. Proteins. 2016;85:561-70.
21. Wang XQ, Sun P, O'Gorman M, Tai T, Paller AS. Epidermal growth factor receptor glycosylation is required for ganglioside gm3 binding and gm3-mediated suppression of activation. Glycobiology. 2001;11:515-22.
22. Prakash A, Janosi L, Doxastakis M. Self-association of models of transmembrane domains of erbb receptors in a lipid bilayer. Biophys J. 2010;99:3657-65.
23. Lopez PH, Schnaar RL. Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol. 2009;19:549-57.
24. Soderquist AM, Carpenter G. Glycosylation of the epidermal growth factor receptor in a-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem. 1984;259:12586-94.
25. Kaszuba K, Grzybek M, Orłowski A, Danne R, Róg T, Simons K, Coskun Ü, Vattulainen I. N-glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc Natl Acad Sci. 2015;112:4334-9.
26. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J. Human epidermal growth factor receptor cdna sequence and aberrant expression of the amplified gene in a431 epidermoid carcinoma cells. Nature. 1984;309:418-25.
27. Slieker LJ, Martensen TM, Lane MD. Synthesis of epidermal growth factor receptor in human a431 cells. Glycosylation-dependent acquisition of ligand binding activity occurs post-translationally in the endoplasmic reticulum. J Biol Chem. 1986;261:15233-41.
28. Sordella R, Bell DW, Haber DA, Settleman J. Gefitinibsensitizing egfr mutations in lung cancer activate antiapoptotic pathways. Science. 2004;305:1163-7.
29. Lopezsambrooks C, Shrimal S, Khodier C, Flaherty DP, Rinis N, Charest JC, Gao N, Zhao P, Wells L, Lewis TA. Oligosaccharyltransferase inhibition induces senescence in rtk-driven tumor cells. Nat Chem Biol. 2016;12:1023-30.
30. Christiansen MN, Chik J, Lee L, Anugraham M, Abrahams JL, Packer NH. Cell surface protein glycosylation in cancer. Proteomics. 2014;14:525-46.
31. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, Dennis JW. Complex n-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 2007;129:123-34.
32. Barel M, Charbit A. Role of glycosylation/deglycolysation processes in francisella tularensis pathogenesis. Front Cell Infect Microbiol. 2017;7:71.
33. Cummings RD, Soderquist AM, Carpenter G. The oligosaccharide moieties of the epidermal growth factor receptor in a-431 cells. Presence of complex-type n-linked chains that contain terminal n-acetylgalactosamine residues. J Biol Chem. 1985;260:11944-52.
34. Zhen Y, Caprioli RM, Staros JV. Characterization of glycosylation sites of the epidermal growth factor receptor. Biochemistry. 2003;42:5478-92.
35. Kolch W, Pitt A. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer. 2010;10:618-29.
36. Sato Y, Takahashi M, Shibukawa Y, Jain SK, Hamaoka R, Miyagawa J, Yaginuma Y, Honke K, Ishikawa M, Taniguchi N. Overexpression of n-acetylglucosaminyltransferase iii enhances the epidermal growth factor-induced phosphorylation of erk in helas3 cells by up-regulation of the internalization rate of the receptors. J Biol Chem. 2001;276:11956-62.
37. Takahashi R, Takeshita F, Honma K, Ono M, Kato K, Ochiya T. Ribophorin ii regulates breast tumor initiation and metastasis through the functional suppression of gsk3[bgr]. Sci Rep. 2013;3:2474.
38. Ge X, Loh HH, Law PY. Mu-opioid receptor cell surface expression is regulated by its direct interaction with ribophorin i. Mol Pharmacol. 2009;75:1307-16.
39. Wilson CM, Roebuck Q, High S. Ribophorin i regulates substrate delivery to the oligosaccharyltransferase core. Proc Natl Acad Sci U S A. 2008;105:9534-9.
40. Aleem E, Kiyokawa H, Kaldis P. Cdc2-cyclin e complexes regulate the g1/s phase transition. Nat Cell Biol. 2005;7:831-6.
41. Santamaría D, Barrière C, Cerqueira A, Hunt S, Tardy C, Newton K, Cáceres JF, Dubus P, Malumbres M, Barbacid M. Cdk1 is sufficient to drive the mammalian cell cycle. Nature. 2007;448:811-5.
42. Sarkars R, Mukherjee S, Roy M. Targeting heat shock proteins by phenethyl isothiocyanate results in cell-cycle arrest and apoptosis of human breast cancer cells. Nutr Cancer. 2013;65:480-93.
43. Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K, Baba H. Rpn2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma. Br J Cancer. 2012;107:1233-8.
44. Yuan TM, Liang RY, Chueh PJ, Chuang SM. Role of ribophorin ii in the response to anticancer drugs in gastric cancer cell lines. Oncol Lett. 2015;9:1861-8.
45. Lian M, Fang J, Han D, Ma H, Feng L, Wang R, Yang F. Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma. PLoS One. 2013;8:e84854.
46. Fujimoto D, Goi T, Hirono Y. Expression of ribophorine ii is a promising prognostic factor in human gastric adenocarcinoma. Int J Oncol. 2016;50:448-56.
47. Ma LJ, Wu WJ, Wang YH, Wu TF, Liang PI, Chang IW, He HL, Li CF. Spock1 overexpression confers a poor prognosis in urothelial carcinoma. J Cancer. 2016;7:467-76.